A Hat Tip to Pharmalittle
Filed under: Health Policy Community, Pharma
Health Reform Watch wishes to congratulate the folks over at Pharmalittle for being named one of the Top 100 Pharma Blogs. They deserve it–and if you’ve never checked out their site– I highly encourage you to do so. Upon the dissolution of Ed Silverman’s Pharmalot, which was hosted here in Newark by the Star Ledger, a group of contributors and commenters banded together to pick up the mantle. For those of you who have a keen interest in Pharma (and who doesn’t?), you’ll find truly insightful and often witty commentary over at Pharmalittle. As an example, this post of theirs announcing their Top 100 status is classic:
Pharmalittle to be Honored at White House
OK, so we lied. It’s all part of the same strategy. As the impressive badge on the left (suitable for framing) shows, this blog has been named one of the top 100 pharma blogs. Did anyone know there were that many pharma blogs?
Anyway, a lot of people out there will wonder how we accomplished this. It’s simple. We followed basic marketing principles:
1. We promoted the blog for off-label uses. For example, it makes a great eye chart and may help slow the growth of cataracts.
2. We gave kickbacks to everyone on the internet. Really.
3. We buried studies 34, 57, and 105.
4. We changed the endpoints in study 35 and left out the last six months of data.
5. We delayed the appearance of generic Pharmalittle (liloxazorx) through a bunch of nuisance suits.
6. We intimidated people who read other blogs.
7. We hired Key Opinion Leaders like Anonymous to talk us up.
8. We funded studies showing all the dangers of other pharma blogs.
9. We convinced people that failure to read Pharmalittle will result in the end of innovation in the industry and the complete dissolution of life-saving medications.
10. We avoided being bought by Pfizer.
11. There is no evidence reading Pharmalittle leads to weight gain, morbid obesity, and diabetes. And anyone who thinks differently will never find Study 57 anyway.
12. We don’t believe in morbid obesity. If you’re going to be obese, at least be up-beat about it.
And stuff like that.
Read more from Pharmalittle here.
Posts from Health Reform Watch have been cited by media sources throughout the country, including Kaiser Health News, The Health Care Blog, NPR's Planet Money Blog, Duke Univ. Med. Center News, American Health Line Alerts, BusinessWeek.com, Concurring Opinions, Balkinization, The New England Journal of Medicine, Harvard's Nieman Foundation for Journalism, The New York Times, Washington Post, L.A. Times, Las Vegas Sun, Maggie Mahar, Ezra Klein, Tom Geoghegan, and the official homepage of the Office of the Democratic Majority Leader of the House of Representatives, Steny Hoyer.
